Encepheal Therapeutics

EncepHeal develops medications to treat substance abuse, starting…

Y CombinatorSummer 2019InactiveHealthcareTherapeuticsTherapeuticsDrug discovery

What they do

Problem

There are no FDA-approved medications to treat stimulant use disorder (e.g., cocaine and methamphetamine addiction).

Solution

The company develops small-molecule therapeutics that are atypical dopamine transporter inhibitors designed to reduce craving and positive reinforcement without being addictive.

Who it's for

Clinicians and healthcare systems treating patients with stimulant use disorder.

Founders

Aaron Lazarus

Founder

I am the former founder and CEO of EncepHeal Therapeutics, developing medications for substance abuse. Prior to EncepHeal, I graduated with my undergraduate and graduate degrees from Wake Forest University. I currently live in North Carolina, but I am originally from South Jersey. When I am not working, I try to go skiing, which is unfortunately hard to do living in North Carolina. I am the most accessible over email.

LinkedIn · X